The latest Synapse news

Synapse CEO announcement

Synapse Electroceutical today announced that the Board of Directors has appointed Andy Boyes as Interim Chief Executive Officer. John Gildersleeve will assume the role of Business Development Director and will continue to serve as an execut..
08-Jun-2018

Synapse Electroceutical is pleased to announce that Andy Boyes has joined the Board

Synapse Electroceutical is pleased to announce that Andy Boyes has joined the Board as an Independent Non-Executive Director. Andy has enjoyed a successful, 32 year career at Smith & Nephew, the FTSE 100 medical technology business engage..
20-Dec-2017

Venous leg ulcer management in clinical practice in the UK: costs and outcomes

Venous leg ulcer management in clinical practice in the UK: costs and outcomes’ published in the International Wound Journal Cost-effective management and healing of VLUs remains a challenging problem for the NHS. The study found that the a..
18-Dec-2017

Right Care, Right Time - An evaluation using an electroceutical treatment

Right Care, Right Time - An evaluation using an electroceutical treatment* to determine the clinical outcomes in a large NHS Trust’ poster presented at Wounds UK Significant wound size reduction and healing. Within the 20 week period follo..
30-Nov-2017

Accel-Heal® treatment in a large NHS Trust

The results of a clinical evaluation of Accel-Heal® electroceutical treatment in a large NHS Trust’ published in Wounds UK A large NHS trust performed an evaluation to establish the clinical outcomes and experiences for patients and hea..
24-Nov-2017

Breaking the cycle of hard-to-heal wounds with electroceutical treatment

Breaking the cycle of hard-to-heal wounds with electroceutical treatment (3401 KB) Breaking the cycle of hard-to-heal wounds with electroceutical treatment
Breaking the cycle of hard-to-heal wounds with electroceutical treatment Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer Bucks New University, Wounds UK Bristol Nurse Symposium, October 2017

..
19-Oct-2017

Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds

Using electroceutical treatment to reduce symptoms and improve healing in chronic wounds, published in Primary Health Care. Use of electroceutical treatment effectively restores the current of injury, expediting normal healing and reducing chroni..
30-Jul-2017

The health economic burden that acute and chronic wounds impose on an average clinical commissioning

The health economic burden that acute and chronic wounds impose on an average clinical commissioning group / health board in the UK’ published in the Journal of Wound Care It is estimated that the annual prevalence of chronic wounds is ..
23-Jun-2017

Health economic burden that different wound types impose on the UK’s National Health Service

Of the £5.3 billion the NHS spend every year treating wounds, over £3.0 billion a year is spent on managing chronic wounds (leg ulcers, diabetic foot ulcers and pressure sores) alone. The majority (74%) of this spend was on wounds tha..
20-Apr-2017

Electrical stimulation therapy and electroceutical treatment for the management of venous leg ulcers

The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to bo..
15-Mar-2017